Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp Nerve Block vs Infiltration for Aneurysm Clipping
NCT03073889Unknown
- Sponsor
- Xiyang Pharmaceutical
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in cerebral aneurysm (3 arms), sponsored by Xiyang Pharmaceutical. Primary endpoint: Change of Interleukin-10 at 24 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
cerebral aneurysm
Beyond the preview
Go deeper on NCT03073889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073889.